Journal Report

ONCOGENE

Download PDF
Journal Information
Journal Title
ONCOGENE
Publisher
SPRINGERNATURE
ISSN
0950-9232
E-ISSN
1476-5594
Database
Clarivate
Domain
Health Sciences, Life Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
B3GNT9-mediated O-glycosylation reprograms fatty acid metabolism in peroxisomes to promote invasion progression of peritumoral glioma cells
Zechuan Peng, Jiasheng Zhong, Shengsong Fu et al.
2026-11-10
DOI: 10.1038/s41388-026-03994-4
Editorial Expression of Concern: Identification of novel VHL targets that are associated with the development of renal cell carcinoma
M. Abdulrahman, E. N. Maina, M. R. Morris et al.
2026-11-9
DOI: 10.1038/s41388-026-04045-8
Retraction Note: Ionizing radiation-induced NF-κB activation requires PARP-1 function to confer radioresistance
S. J. Veuger, J. E. Hunter, B. W. Durkacz
2026-11-9
DOI: 10.1038/s41388-026-04057-4
RHBDL2 promotes cancer stemness and chemoresistance in triple-negative breast cancer through EGFR/PI3K/AKT/mTOR/c-Myc pathway
Dan Wang, Xing Niu, Jingqi Tian et al.
2026-11-5
DOI: 10.1038/s41388-026-04007-0
Therapy-induced tumour senescence drives oxaliplatin resistance via ADORA1–dependent palmitic acid metabolic reprogramming in colorectal cancer
Yuqin Long, Xue Li, Yunxi Zhu et al.
2026-11-3
DOI: 10.1038/s41388-026-04024-z
Disassembly of PKA holoenzyme organization marks prostate cancer progression
Tal Benjamin-Zukerman, Ran Katz, Gilat Shimon et al.
2026-11-3
DOI: 10.1038/s41388-026-04042-x
Early temporal transcriptional and cytokine responses distinguish chemotherapy sensitivity in patient-derived xenograft models of triple-negative breast cancer
Amanda L. Rinkenbaugh, Gloria V. Echeverria, Jiansu Shao et al.
2026-11-2
DOI: 10.1038/s41388-026-04041-y
SIRT3 deficiency triggers mitochondrial dysfunction-associated senescence to suppress colorectal cancer progression via SLC25A13 acetylation
Wei Liu, Hongyao Li, Xuelan Ma et al.
2026-10-31
DOI: 10.1038/s41388-026-04037-8
Dual mTORC1/2 and Scd1 inhibition uncovers a therapeutic vulnerability in pancreatic cancer
Chao Fang, Yuanyuan Yu, Yiping Yin et al.
2026-10-31
DOI: 10.1038/s41388-026-04026-x
KDM1A promotes colorectal cancer progression by regulating NRP2 and VEGFA-related signaling
Guangwei Yang, Zitian Liu, Xiang Zhao et al.
2026-10-31
DOI: 10.1038/s41388-026-04038-7
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 12, 2026 07:15